SC
Therapeutic Areas
1cBio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| OC-1/ALE1 | Hypophosphatasia (HPP) | Phase 1/2a |
| OC-3 | Prostate, Ovarian, Breast, Pancreatic Cancers | Preclinical |
| CDK7 Inhibitors | Solid Tumors, Breast Cancer (incl. brain metastasis) | Discovery/Preclinical |
Leadership Team at 1cBio
AP
Andrew Protter, Ph.D.
CEO
SP
Son Pham, Ph.D.
Co-founder and Vice-President of Chemistry
PJ
Prashant Jain
CFO
SE
Stephen Eck, M.D., Ph.D.
Board of Directors
VB
V. Bryan Lawlis, Ph.D.
Board of Directors
EC
Eliza Chakravarty, M.D.
Board of Directors
AW
Andrew Wong
Board of Directors